487 filings
Page 9 of 25
6-K
tpxa8i180q12450r40l
13 Apr 21
Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch
7:45am
6-K
1v96qb
31 Mar 21
Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial Results
8:27am
6-K
iumjzer w3
12 Mar 21
Report of Foreign Private Issuer
8:56am
SC 13G/A
xdu0jgs3xfg
12 Feb 21
Auris Medical Holding / Altium Capital Management ownership change
5:15pm
6-K
svxxv2x
15 Jan 21
Report of Foreign Private Issuer
4:38pm
424B5
nlqtd7jopngp4v
15 Jan 21
Prospectus supplement for primary offering
4:32pm
S-8
vx766zmd
15 Jan 21
Registration of securities for employees
4:05pm
6-K
e7gf0grpvv1tazc3f
10 Dec 20
Report of Foreign Private Issuer
8:01am
SC 13D/A
ezkn0
7 Dec 20
Auris Medical Holding / Meyer Thomas ownership change
3:49pm
6-K
lrctchwbeo 0zin
3 Dec 20
Auris Medical Holding LTD. Prices $8,000,000 Common Shares Offering Priced At-the-market
5:26pm
424B5
uxy63jo0496j2s mayl
3 Dec 20
Prospectus supplement for primary offering
5:25pm
6-K
ew1vyv w39pi33ni9d7
2 Dec 20
Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
7:01am
424B3
6npody62k4lcc3 zs3
16 Nov 20
Prospectus supplement
5:05pm
424B3
908pz
16 Nov 20
Prospectus supplement
5:00pm
EFFECT
xjubdvvbthc 7od5of5
2 Nov 20
Notice of effectiveness
12:20am
CORRESP
12ei8
21 Oct 20
Correspondence with SEC
12:00am
6-K
pyv80b5bzn2r
9 Oct 20
Report of Foreign Private Issuer
4:30pm
UPLOAD
4zf9qh5nybr
9 Oct 20
Letter from SEC
12:00am
F-3
qb2ie
6 Oct 20
Shelf registration (foreign)
5:02pm